Read more
Zusatztext This is a complex book which addresses many issues apposite to the access to medicines from world agreements and organizations such as TRIPS and dispute settlements by the WTO. It has been very well researched and provides much food for thought for both those involved in institutional policy making and local people in need of easy access to medicines. Informationen zum Autor Hiroko Yamane is a Professor (emeritus) of Law at the National Graduate Institute for Policy Studies (GRIPS) in Tokyo, Japan. Zusammenfassung This book examines Intellectual Property Rights against the backdrop of development and the transfer of technology between globalised economies. Inhaltsverzeichnis Introduction Part I Background1 Innovation Incentives 2 International IP Cooperation and Developing Country Perspectives 3 Biotech Inventions and Patentable Subject Matter Part II The TRIPS Agreement4 Uruguay Round Negotiations and the Adoption of TRIPS 5 The TRIPS Agreement de Lege Lata: the Outline 6 Various Methods of Interpretation: WTO Agreements and the Vienna Convention on the Law of Treaties 7 TRIPS Provisions as Interpreted by the WTO Dispute Settlement Organs Part III Access to Medicines8 T he AIDS Epidemic and TRIPS 9 Doha Declaration and Beyond Part IV IP and Industrial Policies10 Emerging Economies' IP and Industrial Policies 11 Pharmaceutical Industries, R&D and Public Health in Emerging Economies 388Part V TRIPS Flexibilities and National Implementation12 TRIPS Flexibilities and National Implementation (1) Patentable Subject Matter and Patentability Requirements 13 TRIPS Flexibilities and National Implementation (2) Protection of Test Data Submitted to Regulatory Authorities 14 'TRIPS Plus' Provisions in US Free Trade Agreements Part VI Interpreting TRIPS for Innovation15 Recasting the Debate on Intellectual Property Rights
